A detailed history of Roundview Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Roundview Capital LLC holds 15,083 shares of BMY stock, worth $620,212. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,083
Previous 19,154 21.25%
Holding current value
$620,212
Previous $982,000 16.8%
% of portfolio
0.07%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $195,326 - $221,462
-4,071 Reduced 21.25%
15,083 $817,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $452,851 - $540,376
-9,341 Reduced 32.78%
19,154 $982,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $155,897 - $174,317
-2,693 Reduced 8.63%
28,495 $1.65 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $7,454 - $8,276
-117 Reduced 0.37%
31,188 $1.99 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $3,679 - $4,173
-56 Reduced 0.18%
31,305 $2.17 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $245,774 - $291,032
3,589 Added 12.92%
31,361 $2.26 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $452 - $267,249
3,478 Added 14.32%
27,772 $1.97 Million
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $24,472 - $26,953
-337 Reduced 1.37%
24,294 $1.87 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $69,779 - $83,672
1,135 Added 4.83%
24,631 $1.8 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $837,325 - $976,124
-15,613 Reduced 39.92%
23,496 $1.47 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $178,279 - $208,831
3,013 Added 8.35%
39,109 $2.31 Million
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $681 - $741
11 Added 0.03%
36,096 $2.41 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $40,351 - $45,383
680 Added 1.92%
36,085 $2.28 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $55,834 - $63,270
-967 Reduced 2.66%
35,405 $2.2 Million
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $156,496 - $173,419
-2,725 Reduced 6.97%
36,372 $2.19 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $131,184 - $153,367
2,393 Added 6.52%
39,097 $2.3 Million
Q1 2020

May 11, 2020

BUY
$46.4 - $67.43 $484,926 - $704,710
10,451 Added 39.81%
36,704 $2.05 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $233,550 - $304,645
4,746 Added 22.07%
26,253 $1.69 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $91,313 - $108,265
-2,135 Reduced 9.03%
21,507 $1.09 Million
Q2 2019

Aug 12, 2019

SELL
$44.62 - $49.34 $273,520 - $302,454
-6,130 Reduced 20.59%
23,642 $1.07 Million
Q1 2019

May 09, 2019

SELL
$45.12 - $53.8 $36,817 - $43,900
-816 Reduced 2.67%
29,772 $1.42 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $75,041 - $97,310
1,539 Added 5.3%
30,588 $1.59 Million
Q3 2018

Nov 07, 2018

BUY
$55.19 - $62.25 $6,126 - $6,909
111 Added 0.38%
29,049 $1.8 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $750,623 - $935,567
14,855 Added 105.48%
28,938 $1.6 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $84,487 - $97,261
-1,410 Reduced 9.1%
14,083 $891,000
Q4 2017

Feb 07, 2018

BUY
$59.94 - $65.35 $181,798 - $198,206
3,033 Added 24.34%
15,493 $949,000
Q3 2017

Nov 13, 2017

SELL
$55.23 - $63.74 $50,811 - $58,640
-920 Reduced 6.88%
12,460 $794,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $738,977 - $852,841
13,380
13,380 $746,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $87.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Roundview Capital LLC Portfolio

Follow Roundview Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roundview Capital LLC with notifications on news.